1. Home
  2. TLSA vs SRBK Comparison

TLSA vs SRBK Comparison

Compare TLSA & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • SRBK
  • Stock Information
  • Founded
  • TLSA 2013
  • SRBK 1887
  • Country
  • TLSA United Kingdom
  • SRBK United States
  • Employees
  • TLSA N/A
  • SRBK N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • SRBK
  • Sector
  • TLSA Health Care
  • SRBK
  • Exchange
  • TLSA Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • TLSA 87.8M
  • SRBK 104.5M
  • IPO Year
  • TLSA 2000
  • SRBK N/A
  • Fundamental
  • Price
  • TLSA $0.74
  • SRBK $11.99
  • Analyst Decision
  • TLSA
  • SRBK
  • Analyst Count
  • TLSA 0
  • SRBK 0
  • Target Price
  • TLSA N/A
  • SRBK N/A
  • AVG Volume (30 Days)
  • TLSA 442.0K
  • SRBK 18.8K
  • Earning Date
  • TLSA 01-28-2025
  • SRBK 01-01-0001
  • Dividend Yield
  • TLSA N/A
  • SRBK N/A
  • EPS Growth
  • TLSA N/A
  • SRBK N/A
  • EPS
  • TLSA N/A
  • SRBK 0.11
  • Revenue
  • TLSA N/A
  • SRBK $30,867,000.00
  • Revenue This Year
  • TLSA N/A
  • SRBK N/A
  • Revenue Next Year
  • TLSA N/A
  • SRBK N/A
  • P/E Ratio
  • TLSA N/A
  • SRBK $105.06
  • Revenue Growth
  • TLSA N/A
  • SRBK 164.18
  • 52 Week Low
  • TLSA $0.41
  • SRBK $8.94
  • 52 Week High
  • TLSA $1.74
  • SRBK $12.76
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 44.91
  • SRBK 56.32
  • Support Level
  • TLSA $0.68
  • SRBK $11.78
  • Resistance Level
  • TLSA $0.80
  • SRBK $11.95
  • Average True Range (ATR)
  • TLSA 0.08
  • SRBK 0.18
  • MACD
  • TLSA 0.01
  • SRBK -0.03
  • Stochastic Oscillator
  • TLSA 34.34
  • SRBK 41.92

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: